Deep Genomics the company operates an AI-powered genetic medicine discovery tool with a focus on interpreting genetic variation. Leveraging high-throughput assays and advanced robotics systems, their AI platform generates billions of data points and constructs numerous engineered and validated machine learning systems. These systems play a crucial role in supporting drug development by assisting researchers in classifying, prioritizing, interpreting, and establishing connections among genetic variants, both natural and therapeutic.
$180M • 2021 • Series C
Deep Genomics sees AI taking center stage in medicine, surpassing the complexity of biology beyond human comprehension.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!